Alan Nurden: Honoring the Legacy of Dr. Richard Aster
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared Versiti Blood Research Institute’s post on LinkedIn, adding:
“This is very sad news indeed.
Richard Aster was a true pioneer for platelet immunology making valuable contributions all along an outstanding career.
I first met with him in 1980 when he visited Paris to see Tom Kunicki who was performing post-doctoral studies in my group.
Prior to this, Richard Aster and Tom had established that the major platelet receptors were targets for certain drug-dependent antibodies.
Richard’s contribution towards establishing the Blood Center in Milwaukee as a world-leading center for platelet research was enormous and his legacy is shown by the quality of the large number of researchers/clinicians who he trained and mentored.
Never forgetting to orientate his research towards blood transfusion and the clinic, Richard was one of the greats of our field. He will be sorely missed.”
Versiti Blood Research Institute shared a post on LinkedIn:
“Today we remember Richard Herbert ‘Dick’ Aster, whose life and work helped shape modern blood medicine and the future of blood health research.
Dr. Aster joined the Milwaukee Blood Center, now Versiti, in 1970 and later served as president and CEO.
Over the decades that followed, he helped build the scientific, clinical and organizational foundations that continue to support patients, hospitals, researchers and communities today.
A physician, scientist, mentor and teacher, Aster believed research and patient care should advance together.
His work transformed understanding of immune platelet disorders and influenced generations of physicians and scientists in hematology and transfusion medicine.
Those who knew him often speak first about his humility, intellectual curiosity and steady leadership.
His impact continues through the science he advanced, the people he mentored and the mission he helped strengthen.
We extend our deepest sympathies to his wife, Sara ‘Patsy,’ his family, friends and colleagues across the scientific and medical communities.
Read more about his legacy.”
Find more posts featuring Alan Nurden and Versiti Blood Research Institute on Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice